Straumann Holding AG said second-quarter revenue rose 14.1% on an as-reported basis and raised its outlook for 2019.
Group revenue totaled CHF407.8 million on an as-reported basis from CHF357.3 million in 2018.
Second-quarter revenue rose 15.6% year over year on an organic basis.
Revenue in Europe, the Middle East and Africa grew on a yearly basis to CHF174.2 million from CHF156.9 million, mainly driven by the company's bone level tapered implants and BLX dental implants.
Additionally, revenue in North America rose to CHF120.2 million from CHF99.8 million, while in Asia-Pacific, revenue climbed to CHF75.4 million from CHF66.1 million, a year earlier.
In Latin America, Straumann booked CHF38 million revenue, up from CHF34.5 million in the year-ago quarter.
For the first-half of 2019, group revenue amounted to CHF780 million, up from CHF681.5 million, in the corresponding period of 2018.
The company raised its outlook for the full-year, with organic revenue growth from the low-teens to the low-to-mid-teen percentage range from the prior estimate in the low-teen percentage range.
Basel, Switzerland-based Straumann provides tooth replacement solutions worldwide.